Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Blueblood Ventures IPO and Ganga Pharmaceuticals IPO.
Blueblood Ventures IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Ganga Pharmaceuticals IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Quintessence Enterprises Private Limited | First Overseas Capital Limited |
| Registrar | Skyline Financial Services Private Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | ||
| RHP | RHP  |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Blueblood Ventures IPO is up to ₹7.04 Cr whereas the issue size of the Ganga Pharmaceuticals IPO is up to ₹1.54 Cr. The final issue price of Blueblood Ventures IPO is ₹50.00 per share and of Ganga Pharmaceuticals IPO is ₹15.00 per share.
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹50.00 per share | ₹15.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 8000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 14,07,000 shares | 10,24,000 shares |
| Issue Size Total (Amount) | up to ₹7.04 Cr | up to ₹1.54 Cr |
Blueblood Ventures IPO opens on Jan 21, 2016, while Ganga Pharmaceuticals IPO opens on Jan 29, 2016. The closing date of Blueblood Ventures IPO and Ganga Pharmaceuticals IPO is Jan 27, 2016, and Feb 09, 2016, respectively.
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 21, 2016 | Jan 29, 2016 |
| Issue Close | Jan 27, 2016 | Feb 09, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Blueblood Ventures IPO P/E ratio is , as compared to Ganga Pharmaceuticals IPO P/E ratio of .
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Blueblood Ventures IPO retail investors (RII) are offered while in Ganga Pharmaceuticals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Blueblood Ventures IPO and in Ganga Pharmaceuticals IPO.
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Blueblood Ventures IPO subscribed in total, whereas Ganga Pharmaceuticals IPO subscribed .
| Blueblood Ventures IPO | Ganga Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
